Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation

被引:14
|
作者
Del-Rey, Manuel J.
Manzanares, Javier
Bosque, Alberto
Aguilo, Juan I.
Gomez-Rial, Jose
Roldan, Ernesto
Serrano, Antonio
Anel, Alberto
Paz-Artal, Estela
Allende, Luis M. [1 ]
机构
[1] Univ Madrid, Hosp 12 Octubre, Serv Inmunol, Madrid, Spain
[2] Univ Madrid, Hosp 12 Octubre, Secc Gastroenterol Pediat, Madrid, Spain
[3] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50009 Zaragoza, Spain
[4] Hosp Ramon y Cajal, Serv Inmunol, E-28034 Madrid, Spain
关键词
ALPS; apoptosis; Fas; primary immunodeficiency;
D O I
10.1016/j.imbio.2006.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder characterized by chronic lymphoproliferation, autoimmune manifestations and expansion of TCRY alpha beta(+)CD4(-)CD8(-) lymphocytes. The main pathogenic factor is a defective Fas-mediated apoptosis generally caused by mutations in the Fas gene. This report describes a new heterozygous Fas gene mutation in a boy with clinical and immunological features of ALPS. In vitro, T-cell blasts from the patient are completely resistant to the effects on the anti-Fas cytotoxic mAb CH-11, they also have a higher proliferation rate than T cells from healthy donors, while PHA-induced AICD is normal. The location of the mutation (I246S) found in the intracytoplasmic death domain, and the conservation of that residue in four different species from human suggest that 1246 is an essential amino acid for Fas function. The patient has inherited the mutation from his father who also shows defective Fas-mediated apoptosis but the clinical and immunological manifestations are much less severe. These results provide evidence that the penetrance of genetic defects in Fas is variable and that other factors may influence the phenotype of the disease. (c) 2007 Elsevier GrnbH. All rights reserved.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 50 条
  • [41] Pathology of human autoimmune lymphoproliferative syndrome associated with fas gene mutations
    Lim, MS
    StetlerStevenson, M
    Straus, SE
    Sneller, MC
    Dale, JK
    Strober, W
    Jaffe, ES
    LABORATORY INVESTIGATION, 1996, 74 (01) : 671 - 671
  • [42] Fas (CD95) mutations in a kindred with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall, AI
    Pinto, A
    Auer, I
    Woodman, RC
    BLOOD, 1998, 92 (10) : 23A - 23A
  • [43] The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
    Straus, SE
    Jaffe, ES
    Puck, JM
    Dale, JK
    Elkon, KB
    Rösen-Wolff, A
    Peters, AMJ
    Sneller, MC
    Hallahan, CW
    Wang, J
    Fischer, RE
    Jackson, CM
    Lin, AY
    Bäumler, C
    Siegert, E
    Marx, A
    Vaishnaw, AK
    Grodzicky, T
    Fleisher, TA
    Lenardo, MJ
    BLOOD, 2001, 98 (01) : 194 - 200
  • [44] Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS)
    Lambert, Michele P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (11) : 1163 - 1173
  • [45] Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS)
    Tommasini, Alberto
    Valencic, Erica
    Piscianz, Elisa
    Rabusin, Marco
    PEDIATRIC BLOOD & CANCER, 2012, 58 (02) : 310 - 310
  • [46] Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS)
    Li, Pu
    Huang, Ping
    Yang, Ye
    Hao, Mu
    Peng, Hongwei
    Li, Fei
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 50 (01) : 55 - 63
  • [47] AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) A CASE STUDY
    Willis, Catherine
    McGettigan, Benjamin
    Mallon, Dominic
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 25 - 26
  • [48] Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
    Bi, Lilia L.
    Pan, George
    Atkinson, T. Prescott
    Zheng, Lixin
    Dale, Janet K.
    Makris, Christopher
    Reddy, Vishnu
    McDonald, Jay M.
    Siegel, Richard M.
    Puck, Jennifer M.
    Lenardo, Michael J.
    Straus, Stephen E.
    BMC MEDICAL GENETICS, 2007, 8
  • [49] Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS)
    Pu Li
    Ping Huang
    Ye Yang
    Mu Hao
    Hongwei Peng
    Fei Li
    Clinical Reviews in Allergy & Immunology, 2016, 50 : 55 - 63
  • [50] A new peak to the ALPS:: a report of two cases with autoimmune lymphoproliferative syndrome
    Drexel, B.
    Reichenbach, J.
    Schmugge, M.
    Seger, R.
    Guengoer, T.
    SWISS MEDICAL WEEKLY, 2007, 137 : 37S - 37S